A number of clinical trials have been conducted in China in more than 10 hospitals to test the efficacy and safety of chloroquine or hydroxychloroquine in the treatment of #COVID19. The results are quite promising so far. https://t.co/dQjHZapHzl https://t.co/oQzBX1QdV7

Dr. Endo reported "compactin" as a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase. This enzyme regulates the rate-limiting step in cholesterol biosynthesis. https://t.co/wwkSugXrRc https://t.co/dkq67o2PNh 10/